^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

dexamethasone injection

Associations
Company:
Generic mfg.
Drug class:
Steroid receptor agonist, GCR agonist
Associations
5d
New trial
|
dexamethasone injection
6d
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery (clinicaltrials.gov)
P2, N=164, Recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: May 2026 --> May 2027 | Trial primary completion date: May 2026 --> May 2027
Trial completion date • Trial primary completion date
|
gemcitabine • oxaliplatin • dexamethasone • dexamethasone injection
8d
Enrollment closed
|
ABL1 (ABL proto-oncogene 1) • BCR (BCR Activator Of RhoGEF And GTPase)
|
ABL1 T315I
|
dasatinib • cytarabine • Iclusig (ponatinib) • doxorubicin hydrochloride • cyclophosphamide • Blincyto (blinatumomab) • vincristine • mesna • Hemady (dexamethasone tablets) • Starasid (cytarabine ocfosfate) • dexamethasone injection
11d
New trial
|
dexamethasone injection
13d
Enrollment change
|
dexamethasone injection
19d
New P4 trial
|
dexamethasone injection • fosaprepitant • olanzapine
20d
New P1/2 trial
|
TP53 (Tumor protein P53)
|
TP53 deletion
|
Xpovio (selinexor) • carfilzomib • dexamethasone injection • isatuximab subcutaneous (SAR650984 SC)
20d
LS1781: Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (clinicaltrials.gov)
P2, N=80, Recruiting, Mayo Clinic | Trial completion date: Mar 2027 --> Nov 2033 | Trial primary completion date: Mar 2027 --> Feb 2031
Trial completion date • Trial primary completion date
|
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1) • BCL2 (B-cell CLL/lymphoma 2) • IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2) • DNMT3A (DNA methyltransferase 1) • SF3B1 (Splicing Factor 3b Subunit 1) • TET2 (Tet Methylcytosine Dioxygenase 2) • SRSF2 (Serine and arginine rich splicing factor 2) • U2AF1 (U2 Small Nuclear RNA Auxiliary Factor 1) • CD4 (CD4 Molecule) • ZRSR2 (Zinc Finger CCCH-Type, RNA Binding Motif And Serine/Arginine Rich 2)
|
IDH2 mutation • TET2 mutation • SF3B1 mutation • EZH2 mutation • SRSF2 mutation
|
cisplatin • carboplatin • gemcitabine • Rituxan (rituximab) • cytarabine • cyclophosphamide • ifosfamide • oxaliplatin • etoposide IV • decitabine • Truxima (rituximab-abbs) • Hemady (dexamethasone tablets) • Mabtas (rituximab biosimilar) • Starasid (cytarabine ocfosfate) • dexamethasone injection
22d
A Study of Daratumumab (clinicaltrials.gov)
P3, N=500, Recruiting, Janssen Research & Development, LLC | Trial primary completion date: Jan 2026 --> Jan 2029
Trial primary completion date
|
lenalidomide • Darzalex (daratumumab) • carfilzomib • pomalidomide • Darzalex Faspro (daratumumab and hyaluronidase-fihj) • dexamethasone injection
22d
Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults (clinicaltrials.gov)
P=N/A, N=120, Recruiting, Poznan University of Medical Sciences | Not yet recruiting --> Recruiting
Enrollment open
|
dexamethasone injection • ondansetron
22d
The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery (clinicaltrials.gov)
P4, N=60, Completed, Poznan University of Medical Sciences | Recruiting --> Completed
Trial completion
|
dexamethasone injection